Navigation Links


Pharmaceutic Labs Opens CGMP Outsourcing Facility in Albany, NY

10/20/2014
ALBANY, N.Y. , Oct. 20, 2014 Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing fac... [Comments]

Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets

10/20/2014
DENVER , Oct. 20, 2014   Mary's Medicinals today announced that its 501(c)(3) foundation, Mary's Foundation for Caring, is a 4-Star Sponsor of Operation Grow4Vets , a national, nonpartisan organization focused on providing Veterans with unique products, programs and services to assist them in living with injuries sustained while protecting our freedom. Key Facts: A... [Comments]

Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy

10/20/2014
LONDON , October 20, 2014 Norgine B.V. today announced that the Phase II study of its novel, low volume bowel preparation, NER1006, presented at the 79 th Annual Scientific Meeting of the American College of Gastroenterology (ACG), Philadelphia, PA , has met its primary efficacy end point of stool weight and co-primary endpoint of cleansing success. The study demonstrate... [Comments]

The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth

10/20/2014
NEW YORK and RALEIGH, N.C., Oct. 20, 2014  BioPontis Alliance for Rare Disease and the Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today the creation of a joint venture to develop drug candidates for the treatment of the rare disease known as Charcot- Marie-Tooth (CMT) Disease. BioPontis Alliance announced its alliance model earlier this... [Comments]

Interim Chief Financial Officer James Bowling to Step Down

10/19/2014
DUBLIN , October 20, 2014 Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that James Bowling , Interim Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down from his current role to pursue a new career opportunity as CFO of Severn Trent plc.  James will leave Shire at the end of Q1 2015 and the company will commence a search fo... [Comments]

CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014

10/19/2014
SEATTLE, Wash. , Oct. 20, 2014 CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its third quarter 2014 financial results on Wednesday, October 29, 2014, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general cor... [Comments]

Henry Schein Enters Japan With Investment in Iwase Dental Supply

10/19/2014
MELVILLE, N.Y. , Oct. 19, 2014  Henry Schein, Inc. (NASDAQ: HSIC ), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has invested in Iwase Dental Supply, Inc., a leading full-service provider of dental consumables, implants and equipment in Japan.  The tran... [Comments]

Vergleichsbericht zu Pharma-Kühlketten und CRT

10/19/2014
FRANKFURT , Deutschland, October 19, 2014 Große Pharmafirmen werden oft nach echten CRT-Fallstudien gefragt. Das Problem dabei ist, dass große Pharmafirmen nicht willens sind, alle ihre Informationen mit der Kompetenz zu teilen. Es war deshalb nicht einfach, diesen Bericht zusammenzustellen, und deshalb freuen wir uns umso mehr, dass es uns gelungen ist! Wir ha... [Comments]

HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug

10/18/2014
WASHINGTON , Oct. 18, 2014  In a policy paper released today, the Human Rights Campaign (HRC), the nation's largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization, explicitly endorsed the use of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is any medical or public health tool used to prevent the spread of a disease or infection pr... [Comments]

Early Key Findings from the Medical Affairs Consortium Research

10/17/2014
CHAPEL HILL, N.C. , Oct. 17, 2014 With the recent changes in the healthcare landscape, the Medical Affairs function has come across several challenges in creating and utilizing effective metrics, allocating resources efficiently and managing globalization.  The Medical Affairs Consortium at Best Practices, LLC is dedicated to providing benchmarking and best practices... [Comments]

[previous] [next]
(Date:10/20/2014)... October 20, 2014 Based on ... the only imaging assays capable of determining DNA ... test.  With these three dimensions of high-resolution data, ... detect the widest range of disease-causing genetic rearrangements, ... by other genomic tools, including today’s advanced sequencing ...
(Date:10/20/2014)... October 20, 2014 Unveiled at the Sept. ... Direction Scorecard conservatively estimates member hospital ROI on membership dues ... dues, The Center provides $12.50 in value to member hospitals. ... Value – Member Dues)/Member Dues. , “This is the ... number and we think the methodology is really sound,” said ...
(Date:10/20/2014)... Houston, Texas (PRWEB) October 20, 2014 ... invited to present the key elements of his innovative ... visiting professor to plastic surgery residents and faculty at ... (UTMB) , where he, too, was once a medical ... of the largest private cosmetic plastic surgery practices in ...
(Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
(Date:10/19/2014)... 2014 This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ... features on late-stage and discontinued projects. , Partial ...
Breaking Medicine News(10 mins):Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
... and delay in return of spontaneous circulation (ROSC), evidenced ... were both associated with poor neurologic outcomes in post ... Nov. 14 at the at the American Heart Association ... have an appropriate understanding of the patient,s post cardiac ...
... , MONDAY, Nov. 14 (HealthDay News) -- ... to greatly increase the risk of Parkinson,s disease, and ... of developing the neurodegenerative disorder, a new study indicates. ... States have Parkinson,s disease and more than 50,000 new ...
... HealthDay Reporter , SUNDAY, Nov. 13 (HealthDay News) -- ... athletes dying on the playing field due to an undetected ... issued guidelines aimed at helping doctors and coaches detect these ... new research suggests that only a small percentage of physicians ...
... to research linking alcohol to breast cancer risk, a new ... shows that adolescent girls with a family history of breast ... become cancer have a higher risk of developing benign ... girls without a family history, this already-elevated risk rises with ...
... contributes to the increasing evidence that repeated occupational ... for Parkinson,s disease. Researchers analyzed the occupational histories ... developed the neurodegenerative disorder, and assessed that twin,s ... to Parkinson,s. Of the six chemicals investigated, researchers ...
... , SUNDAY, Nov. 13 (HealthDay News) -- Patients who ... for the first time while they are hospitalized with ... death, a new study finds. Atrial fibrillation (AF) ... among critically ill patients, according to background study information. ...
Cached Medicine News:Health News:Better understanding of neurologic defects improves post-cardiac-arrest discharge 2Health News:Exposure to Toxic Solvents Linked to Parkinson's Disease 2Health News:Too Few Doctors Screen Young Athletes for Hidden Heart Trouble 2Health News:Too Few Doctors Screen Young Athletes for Hidden Heart Trouble 3Health News:Girls with family history of breast disease should avoid alcohol 2Health News:Girls with family history of breast disease should avoid alcohol 3Health News:NIH-funded twin study finds occupational chemical exposure may be linked to Parkinson's risk 2Health News:NIH-funded twin study finds occupational chemical exposure may be linked to Parkinson's risk 3Health News:Sepsis Plus Heart Rhythm Disorder Linked to Stroke, Death 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:10/20/2014)... 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Annual Meeting that they have joined forces to ... collaboration is the first of its kind and ... outcomes. NICO,s BrainPath® interventional access technology and Synaptive,s ...
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  AnaptysBio, ... of therapeutic antibodies, today announced the appointment of ... Officer. Dr. Londei will lead the preclinical and ... "We are pleased to welcome Dr. ... Hamza Suria , President and Chief Executive Officer ...
(Date:10/20/2014)... Norgine B.V. today announced that the Phase ... NER1006, presented at the 79 th Annual Scientific ... Philadelphia, PA , has met its primary ... of cleansing success. The study demonstrated high quality bowel ... screening colonoscopy patients. [1] (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a) ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2